Association of Low HDL and HDL2 Cholesterol with Coronary Heart Disease in Noninsulin‐Dependent Diabetics

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Arteriosclerosis

• Publication date

  1985-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.5.6.653PMID 4074198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

  2009cited by this paper
• Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.

  1983cited by this paper
• The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study

  1983cited by this paper
• High-density Lipoprotein Subfractions in Normolipidemic Patients with Coronary Atherosclerosis

  1982cited by this paper
• Metabolism of Cholesterol and Plasma Triglycerides in Nonketotic Diabetes Mellitus

  1982cited by this paper
• Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

  1981cited by this paper
• High Density Lipoproteins in Diabetes

  1981influential reference
• Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol.

  1981cited by this paper
• Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men.

  1981cited by this paper
• Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease. The influence of various risk factors.

  1981cited by this paper
• Plasma lipoproteins in maturity onset diabetes.

  1980cited by this paper
• High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study.

  1979cited by this paper
• High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus.

  1978cited by this paper
• Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

  1978cited by this paper
• The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

  1977cited by this paper
• C-peptide Response to Glucagon: A Test for the Residual β-cell Function in Diabetes Mellitus

  1977cited by this paper
• HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study

  1977cited by this paper
• Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study.

  1977cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• Cardiovascular survey methods.

  1969cited by this paper
• Ischemic Heart Disease, Atherosclerosis, and Longevity

  1966cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• The Role of High-Density Lipoprotein Cholesterol in 2022

  2022cites this paper
• Berkeley Laboratory

  2013cites this paper
• High-density lipoprotein subclasses and their relationship to cardiovascular disease.

  2012cites this paper
• Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes.

  2010cites this paper
• High-density lipoprotein quantity or quality for cardiovascular prevention?

  2010cites this paper
• Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful

  2009cites this paper
• Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review

  2009cites this paper
• Are advanced lipoprotein testing and subfractionation clinically useful

  2009cites this paper
• Telmisartan and enalapril in type 2 diabetes Diabetics Exposed to Telmisartan and Enalapril (DETAIL) study

  2005cites this paper
• ROSIGLITAZONE: POTENTIAL BENEFICIAL IMPACT ON CARDIOVASCULAR DISEASE

  2003cites this paper
• Pathogenesis and Management of Diabetic Dyslipidemia

  2003cites this paper
• Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables.

  2003cites this paper
• HDL in atherosclerosis: actor or bystander?

  2003cites this paper
• Addressing the insulin resistance syndrome: a role for the thiazolidinediones.

  2002cites this paper
• A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men.

  2002cites this paper
• Primary prevention of atherosclerosis and obesity in young adults using dietary and educational interventions

  2002cites this paper
• Lipoprotein Lipase Gene Variation : Association with Ishaemic Heart Disease in Type 2 Diabetes

  2001cites this paper
• High-density lipoprotein: epidemiology, metabolism, and antiatherogenic effects.

  2001cites this paper
• Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.

  2001cites this paper
• Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia

  2000cites this paper
• Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment.

  2000cites this paper
• Comparative analysis of plasma and erythrocyte 7-ketocholesterol as a marker for oxidative stress in patients with diabetes mellitus.

  2000cites this paper
• Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women.

  2000cites this paper
• Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease

  2000cites this paper
• Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans.

  2000cites this paper
• Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

  2000cites this paper
• Pathogenesis of atherosclerosis in diabetes and hypertension.

  1999cites this paper
• Endothelial dysfunction, atherosclerosis and diabetes.

  1999cites this paper
• Insulin Resistance and Dyslipidemia: Implications for Coronary Heart Disease Risk

  1999cites this paper
• Epidemiologic aspects of lipid abnormalities.

  1998cites this paper
• Diabetes und periphere arterielle Verschlußkrankheit

  1998cites this paper
• Effects of Glucose and Insulin on Rat Apolipoprotein A-I Gene Expression*

  1998cites this paper
• Gemfibrozil treatment increases low‐density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability

  1998cites this paper
• Advanced glycation endproducts and the development of accelerated atherosclerosis in diabetic apolipoprotein E deficient mice

  1997cites this paper
• Free fatty acids, insulin resistance and lipoprotein metabolism

  1996cites this paper
• Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism.

  1996cites this paper
• HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.

  1995cites this paper
• Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus

  1995cites this paper
• The effects of gender and type of diabetes on HDL-cholesterol.

  1994cites this paper
• Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism.

  1994cites this paper
• DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro‐ and microangiopathy in non‐insulin‐dependent diabetes mellitus

  1994cites this paper
• Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non‐Insulin‐Dependent Diabetes

  1993cites this paper
• HDL and coronary artery disease.

  1993cites this paper
• Lipids and lipoproteins as risk factors for coronary heart disease in men with abnormal glucose tolerance: the Honolulu Heart Program

  1993cites this paper
• Hypertension, coronary artery disease and insulin resistance—linked disorders with an impact on treatment

  1992cites this paper
• Diabetic Macrovascular Disease and Serum Lipids: Is There a Connection?

  1992cites this paper
• Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria.

  1992cites this paper
• Management of hyperlipidemia in diabetes mellitus.

  1992cites this paper
• Cardiovascular risk factors and prevalence of coronary heart disease in type 2 (non-insulin-dependent) diabetes

  1992cites this paper
• A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

  1991cites this paper
• Relation ofcoronaryheart disease andapolipoprotein Ephenotype in patients with non-insulin dependent diabetes

  1991cites this paper
• Multiple risk factors in coronary artery disease patients with abnormal glucose tolerance.

  1991cites this paper
• Potential mechanisms of the cardioprotective effects of beta blockade

  1991cites this paper
• Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.

  1991cites this paper
• DNA Restriction Polymorphisms of the Apolipoprotein AI‐CIII‐AIV Gene Cluster: a Genetic Determinant of Atherosclerosis in Type 2 (Non‐insulin‐dependent) Diabetes Mellitus

  1991cites this paper
• Hyperlipidaemia in diabetes.

  1990cites this paper
• Acquired hyperlipidemia (secondary dyslipoproteinemias).

  1990cites this paper
• Plasma lipids and lipoproteins in diabetes: lessons from population-based studies.

  1990cites this paper
• Hyperlipidemia in diabetes mellitus.

  1990cites this paper
• Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance

  1990cites this paper
• Fish oil: a panacea?

  1990cites this paper
• Apolipoprotein profile in type II diabetic patients with and without coronary heart disease

  1990cites this paper
• 3 Hyperlipidaemia in diabetes

  1990cites this paper
• Plasma lipids in patients with type I diabetes mellitus. Influence of race, gender, and plasma glucose control: lipids do not correlate with glucose control in black women.

  1989cites this paper
• Lipids, Diabetes, and Vascular Disease: The Time to Act

  1989cites this paper
• Diabetes mellitus und Gefäßkrankheiten — Gesamtschau

  1989cites this paper
• 12 Insulin treatment of non-insulin-dependent diabetes mellitus

  1988cites this paper
• Lipoprotein pattern in long-term diabetes of an at least 35 years' duration

  1988cites this paper
• Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease.

  1988cites this paper
• Lipoprotein subspecies and risk of coronary disease.

  1988cites this paper
• Atherogenic factors in diabetes: the role of lipoprotein metabolism.

  1988cites this paper
• A Balanced Diet?

  1988influential citation
• Treatment of lipid disorders in diabetes mellitus.

  1988cites this paper
• インスリン治療糖尿病における高比重リポ蛋白およびLecithin Cholesterol Acyltransferase活性に及ぼす糖尿病コントロールの効果

  1988cites this paper
• High-density lipoprotein composition in obesity: interrelationships with plasma insulin levels and body weight.

  1988cites this paper
• Dietary Fat and Coronary Heart Disease

  1988cites this paper
• Insulin treatment of non-insulin-dependent diabetes mellitus.

  1988cites this paper
• Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.

  1987cites this paper
• Insulin and HDL-cholesterol metabolism.

  1987cites this paper
• Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.

  1987cites this paper
• Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease.

  1987cites this paper
• Diabetes and atherosclerosis: an epidemiologic view.

  1987cites this paper
• Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus.

  1986cites this paper
• The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed Type 2 (non-insulin-dependent) diabetes

  1985cites this paper